Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.83 AUD | 0.00% | +4.27% | -8.50% |
Mar. 19 | Morgan Stanley Upgrades Baby Bunting to Overweight from Equalweight; Price Target is AU$2.20 | MT |
Feb. 20 | Baby Bunting Shares Drop 12% as H1 FY24 Revenue Declines 2.5%, Profit Slips | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The opinion of analysts covering the stock has improved over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company does not generate enough profits, which is an alarming weak point.
- The company is in debt and has limited leeway for investment
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Other Specialty Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-8.50% | 160M | B | ||
+4.90% | 5.71B | B- | ||
-11.42% | 4.42B | C | ||
+14.25% | 4.17B | C+ | ||
+4.23% | 1.85B | - | B- | |
-4.59% | 1.77B | C+ | ||
-13.78% | 1.26B | - | C | |
-17.17% | 1.15B | B- | ||
-42.26% | 736M | D+ | ||
-2.08% | 613M | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- BBN Stock
- Ratings Baby Bunting Group Limited